Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study compares the efficacy of Hylo-Dual (Hyaluronic acid 0.05% & Ectoine 2.0%) and
Olopatadine (Olopatadine hydrochloride ophthalmic solution 0.1%) in the control of seasonal
allergic conjunctivitis in the pediatric population. Half of participants will receive
Hylo-Dual, while the other half will receive Olopatadine treatment for 2 months.